Gautam Patel Receives Stock Award at Amneal Pharmaceuticals Inc (AMRX) — SEC Form 4, May 06, 2024

SEC Form 4 · No Market Transaction

Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner

Gautam Patel

Director

TXN 2024-05-02 · FILED 2024-05-06

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Amneal Pharmaceuticals Inc

AMRX CIK 0001723128

Reporting Owner

Name	Relationship
Gautam Patel CIK 0001738054	Director

Gautam Patel at Amneal Pharmaceuticals Inc Full insider history

Bought (12 mo) —

Sold (12 mo) —

More from this insider at Amneal Pharmaceuticals Inc

Derivative Securities Transactions

Title	Strike	Date	Type	Shares	Price	Expiration	Underlying	Ownership
Restricted Stock UnitsF1 F2 F2		2024-05-02	A - Award/Grant	40,258 A	$0.00		40,258 Class A Common Stock	Direct

Footnotes (2)

F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Show more
F2: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 6 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Amneal Pharmaceuticals Inc

GET /v1/forms/4/0001628280-24-020741 API docs